1-115976666-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_018420.3(SLC22A15):​c.39G>A​(p.Met13Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000239 in 1,588,756 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000024 ( 0 hom. )

Consequence

SLC22A15
NM_018420.3 missense

Scores

2
3
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.99

Publications

0 publications found
Variant links:
Genes affected
SLC22A15 (HGNC:20301): (solute carrier family 22 member 15) Organic ion transporters, such as SLC22A15, transport various medically and physiologically important compounds, including pharmaceuticals, toxins, hormones, neurotransmitters, and cellular metabolites. These transporters are also referred to as amphiphilic solute facilitators (ASFs).[supplied by OMIM, Apr 2004]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.27805668).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC22A15NM_018420.3 linkc.39G>A p.Met13Ile missense_variant Exon 1 of 12 ENST00000369503.9 NP_060890.2 Q8IZD6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC22A15ENST00000369503.9 linkc.39G>A p.Met13Ile missense_variant Exon 1 of 12 1 NM_018420.3 ENSP00000358515.4 Q8IZD6-1

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
151950
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000442
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000439
AC:
1
AN:
227674
AF XY:
0.00000801
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000951
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000237
AC:
34
AN:
1436806
Hom.:
0
Cov.:
30
AF XY:
0.0000210
AC XY:
15
AN XY:
715044
show subpopulations
African (AFR)
AF:
0.0000320
AC:
1
AN:
31228
American (AMR)
AF:
0.00
AC:
0
AN:
42570
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25492
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37204
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84246
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49770
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5602
European-Non Finnish (NFE)
AF:
0.0000281
AC:
31
AN:
1101324
Other (OTH)
AF:
0.0000337
AC:
2
AN:
59370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
151950
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74230
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41418
American (AMR)
AF:
0.00
AC:
0
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10546
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000442
AC:
3
AN:
67944
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000302
ESP6500AA
AF:
0.000245
AC:
1
ESP6500EA
AF:
0.00
AC:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 03, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.39G>A (p.M13I) alteration is located in exon 1 (coding exon 1) of the SLC22A15 gene. This alteration results from a G to A substitution at nucleotide position 39, causing the methionine (M) at amino acid position 13 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.63
BayesDel_addAF
Benign
-0.029
T
BayesDel_noAF
Benign
-0.28
CADD
Uncertain
25
DANN
Uncertain
0.98
DEOGEN2
Benign
0.0078
T;.
Eigen
Benign
-0.094
Eigen_PC
Benign
0.035
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Benign
0.85
T;T
M_CAP
Pathogenic
0.53
D
MetaRNN
Benign
0.28
T;T
MetaSVM
Benign
-0.65
T
MutationAssessor
Benign
1.2
L;L
PhyloP100
4.0
PrimateAI
Uncertain
0.77
T
PROVEAN
Benign
-0.33
N;N
REVEL
Benign
0.25
Sift
Benign
0.14
T;T
Sift4G
Benign
0.23
T;T
Polyphen
0.0
B;B
Vest4
0.39
MutPred
0.71
Gain of catalytic residue at M13 (P = 0.0936);Gain of catalytic residue at M13 (P = 0.0936);
MVP
0.69
MPC
0.23
ClinPred
0.31
T
GERP RS
4.1
PromoterAI
0.0088
Neutral
Varity_R
0.36
gMVP
0.30
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs371723549; hg19: chr1-116519287; API